MeSH tree: D12.776.631.650
Poor sleep quality has been linked to cognitive decline, neurodegeneration and Alzheimer's disease in older adults. A new international study led by Concordia researchers and published in the journal Neurology shows that ...
Aug 25, 2026
0
37
While most runners are chasing a new goal or a personal best, some are chasing something slightly more elusive: a runner's high.
Aug 6, 2026
0
6
Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is associated with a lower risk of a major cardiovascular event, such as a heart ...
Aug 5, 2026
0
7
Narcolepsy is a chronic neurological condition characterized by disruptions in the regulation of sleep-wake cycles. People with this condition often experience extreme sleepiness during the day and, in some cases, a sudden ...
Have you ever wondered why it feels so good to sing in the shower? Or why turning up the radio in the middle of a traffic jam and singing out loud can put you in a better mood?
Jul 28, 2026
0
17
The use of glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity is associated with an increased risk of hair loss (alopecia) in adults with type 2 diabetes, a study published by The BMJ finds. ...
Jul 22, 2026
0
30
Anyone who has bought medicine online may have wondered whether what arrived in the mail was really what they had paid for. They are not alone. A recent global survey found that around 60% of people fear their medicines could ...
Jul 22, 2026
0
4
Fentanyl causes symptoms that can lead to death from overdose. One of these symptoms is slow breathing, which deprives drug users of oxygen. In new research in JNeurosci, Erica Levitt and colleagues from the University of ...
Jul 20, 2026
0
2
Despite the end of federal shortages of popular GLP-1 weight-loss medications, the market for compounded alternatives remains strong—and some patients may unknowingly be receiving products from pharmacies with concerning ...
Jul 17, 2026
0
7
Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic study offers a potential answer by identifying a distinct biological subtype of obesity that responds ...
Jul 16, 2026
0
8
